mercaptoethanol has been researched along with Uterine Neoplasms in 5 studies
Mercaptoethanol: A water-soluble thiol derived from hydrogen sulfide and ethanol. It is used as a reducing agent for disulfide bonds and to protect sulfhydryl groups from oxidation.
Uterine Neoplasms: Tumors or cancer of the UTERUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of beta-mercaptoethanol (ME) on the steady-state level of mRNA of the human chorionic gonadotropin-beta subunit (hCG-beta) and the intracellular hormonal dynamics of the product protein were examined in BeWo cells, a choriocarcinoma cell line, using Northern blot analysis and a radioimmunoassay (RIA) specific for hCG-beta." | 7.70 | Suppression by beta-mercaptoethanol of the intracellular hormonal dynamics of human chorionic gonadotropin-beta subunit (hCG-beta) in BeWo choriocarcinoma cells. ( Nakamura, K; Yasuda, N, 1998) |
| "The effects of beta-mercaptoethanol (ME) on the steady-state level of mRNA of the human chorionic gonadotropin-beta subunit (hCG-beta) and the intracellular hormonal dynamics of the product protein were examined in BeWo cells, a choriocarcinoma cell line, using Northern blot analysis and a radioimmunoassay (RIA) specific for hCG-beta." | 3.70 | Suppression by beta-mercaptoethanol of the intracellular hormonal dynamics of human chorionic gonadotropin-beta subunit (hCG-beta) in BeWo choriocarcinoma cells. ( Nakamura, K; Yasuda, N, 1998) |
| "Ifosfamide/mesna has activity in a wide range of gynecologic malignancies." | 1.28 | Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies. ( Berman, ML; Blessing, JA; Homesley, HD; Photopulos, G; Sutton, GP, 1989) |
| "Ifosfamide and mesna were administered to 77 patients with advanced malignancies." | 1.27 | Prediction of ifosfamide/mesna associated encephalopathy. ( Blackledge, G; Blake, AE; Honigsberger, L; Kelly, KA; Meanwell, CA, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, K | 1 |
| Yasuda, N | 1 |
| Puisieux, A | 1 |
| Bellet, D | 1 |
| Troalen, F | 1 |
| Razafindratsita, A | 1 |
| Lhomme, C | 1 |
| Bohuon, C | 1 |
| Bidart, JM | 1 |
| Sutton, GP | 1 |
| Blessing, JA | 1 |
| Photopulos, G | 1 |
| Berman, ML | 1 |
| Homesley, HD | 1 |
| Meanwell, CA | 2 |
| Blake, AE | 2 |
| Latief, TN | 1 |
| Blackledge, G | 2 |
| Mould, JJ | 1 |
| Blake, DR | 1 |
| Shaw, IC | 1 |
| Honigsberger, L | 2 |
| Spooner, D | 1 |
| Williams, AC | 1 |
| Kelly, KA | 1 |
5 other studies available for mercaptoethanol and Uterine Neoplasms
| Article | Year |
|---|---|
Suppression by beta-mercaptoethanol of the intracellular hormonal dynamics of human chorionic gonadotropin-beta subunit (hCG-beta) in BeWo choriocarcinoma cells.
Topics: Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Dose-Response Relationship, Drug; Fema | 1998 |
Occurrence of fragmentation of free and combined forms of the beta-subunit of human chorionic gonadotropin.
Topics: Amino Acid Sequence; Blotting, Western; Choriocarcinoma; Chorionic Gonadotropin; Chorionic Gonadotro | 1990 |
Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Ci | 1989 |
Encephalopathy associated with ifosphamide/mesna therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Cyclophosphamide; Female; Humans; If | 1985 |
Prediction of ifosfamide/mesna associated encephalopathy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Electroencephalography; Female; Huma | 1986 |